Vanguard Group’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112M | Buy |
7,025,938
+89,079
| +1% | +$1.43M | ﹤0.01% | 1780 |
|
|
2025
Q1 | $119M | Buy |
6,936,859
+257,445
| +4% | +$4.4M | ﹤0.01% | 1720 |
|
|
2024
Q4 | $165M | Buy |
6,679,414
+20,614
| +0.3% | +$511K | ﹤0.01% | 1632 |
|
|
2024
Q3 | $190M | Buy |
6,658,800
+149,047
| +2% | +$4.25M | ﹤0.01% | 1568 |
|
|
2024
Q2 | $172M | Buy |
6,509,753
+31,449
| +0.5% | +$830K | ﹤0.01% | 1569 |
|
|
2024
Q1 | $209M | Buy |
6,478,304
+650,506
| +11% | +$21M | ﹤0.01% | 1490 |
|
|
2023
Q4 | $246M | Sell |
5,827,798
-405,348
| -7% | -$17.1M | 0.01% | 1387 |
|
|
2023
Q3 | $239M | Buy |
6,233,146
+764,530
| +14% | +$29.4M | 0.01% | 1339 |
|
|
2023
Q2 | $104M | Buy |
5,468,616
+324,907
| +6% | +$6.16M | ﹤0.01% | 1829 |
|
|
2023
Q1 | $79.8M | Buy |
5,143,709
+74,590
| +1% | +$1.16M | ﹤0.01% | 1933 |
|
|
2022
Q4 | $90M | Buy |
5,069,119
+1,068,669
| +27% | +$19M | ﹤0.01% | 1862 |
|
|
2022
Q3 | $22.3M | Buy |
4,000,450
+957
| +0% | +$5.34K | ﹤0.01% | 2585 |
|
|
2022
Q2 | $15.6M | Buy |
3,999,493
+233,780
| +6% | +$912K | ﹤0.01% | 2771 |
|
|
2022
Q1 | $20.8M | Sell |
3,765,713
-68,406
| -2% | -$377K | ﹤0.01% | 2754 |
|
|
2021
Q4 | $32.7M | Buy |
3,834,119
+84,833
| +2% | +$723K | ﹤0.01% | 2581 |
|
|
2021
Q3 | $32.6M | Sell |
3,749,286
-251,411
| -6% | -$2.18M | ﹤0.01% | 2605 |
|
|
2021
Q2 | $42.3M | Buy |
4,000,697
+3,977
| +0.1% | +$42K | ﹤0.01% | 2459 |
|
|
2021
Q1 | $64.1M | Buy |
3,996,720
+118,171
| +3% | +$1.9M | ﹤0.01% | 2174 |
|
|
2020
Q4 | $179M | Buy |
3,878,549
+697,905
| +22% | +$32.2M | 0.01% | 1525 |
|
|
2020
Q3 | $112M | Buy |
3,180,644
+1,490,530
| +88% | +$52.5M | ﹤0.01% | 1635 |
|
|
2020
Q2 | $41.2M | Buy |
+1,690,114
| New | +$41.2M | ﹤0.01% | 2096 |
|